About

Conception.bio focuses on improving fertility treatments through advanced biotechnology. The company has developed a method to create viable egg cells from blood samples by transforming induced pluripotent stem cells (iPSCs) into mature egg cells. This process allows women to extend their fertility, provides options for couples facing infertility, and supports same-sex male couples wanting biological children. Unlike many competitors, Conception.bio emphasizes a collaborative research environment with a team of skilled scientists dedicated to fertility science. The goal is to offer effective solutions for infertility and enhance reproductive health, making it easier for individuals and couples to achieve their family planning goals.

Simplify's Take

What believers are saying

• Growing interest in genetic screening boosts potential partnerships and funding opportunities.
• Advancements in CRISPR enhance Conception's genetic screening and disease prevention capabilities.
• Rising demand for fertility preservation expands Conception's market reach.

What critics are saying

• Ethical concerns about iPSCs could lead to public backlash and regulatory challenges.
• Competition from companies like Dioseve may impact Conception's market share.
• High development costs of stem cell technologies may limit accessibility and adoption.

What makes Conception unique

• Conception uses iPSCs to create viable human eggs from skin cells.
• Their technology allows male-male couples to have biological children.
• Conception offers genetic screening to prevent hereditary diseases in embryos.

Help us improve and share your feedback! Did you find this helpful?

YesNo